6.
Rossini M, Bolzoni A, Piazza C, Peretti G
. Renal cell carcinoma metastatic to the larynx. Otolaryngol Head Neck Surg. 2004; 131(6):1029-30.
DOI: 10.1016/j.otohns.2004.03.019.
View
7.
Rashid A, Ahmed R, Hassan H, Bayz A
. Metastasis of renal cell carcinoma to the vocal cord ten years after radical nephrectomy: A case report. Urol Case Rep. 2019; 28:101059.
PMC: 6921128.
DOI: 10.1016/j.eucr.2019.101059.
View
8.
Silver C, Beitler J, Shaha A, Rinaldo A, Ferlito A
. Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol. 2009; 266(9):1333-52.
DOI: 10.1007/s00405-009-1028-2.
View
9.
Escudier B, Porta C, Schmidinger M, Rioux-Leclercq N, Bex A, Khoo V
. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Ann Oncol. 2019; 30(5):706-720.
DOI: 10.1093/annonc/mdz056.
View
10.
Motzer R, Jonasch E, Agarwal N, Bhayani S, Bro W, Chang S
. Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017; 15(6):804-834.
DOI: 10.6004/jnccn.2017.0100.
View
11.
Yamazaki H, Nishiyama K, Tanaka E, Koizumi M, Chatani M
. Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys. 2005; 64(1):77-82.
DOI: 10.1016/j.ijrobp.2005.06.014.
View
12.
Hittel J, Born I
. [Unusual metastatic site of a kidney carcinoma. A case report with review of the literature]. Laryngorhinootologie. 1995; 74(10):642-4.
DOI: 10.1055/s-2007-997817.
View
13.
Gomez D, Tang C, Zhang J, Blumenschein Jr G, Hernandez M, Lee J
. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study. J Clin Oncol. 2019; 37(18):1558-1565.
PMC: 6599408.
DOI: 10.1200/JCO.19.00201.
View
14.
Zhang Y, Schoenhals J, Christie A, Mohamad O, Wang C, Bowman I
. Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer. Int J Radiat Oncol Biol Phys. 2019; 105(2):367-375.
PMC: 7647381.
DOI: 10.1016/j.ijrobp.2019.07.023.
View
15.
Marvaso G, Corrao G, Oneta O, Pepa M, Zaffaroni M, Corso F
. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?. Clin Transl Oncol. 2021; 23(8):1717-1726.
DOI: 10.1007/s12094-021-02574-0.
View
16.
Maung R, BURKE R, Hwang W
. Metastatic renal carcinoma to larynx. J Otolaryngol. 1987; 16(1):16-8.
View
17.
Demir L, Erten C, Somali I, Can A, Dirican A, Bayoglu V
. Metastases of renal cell carcinoma to the larynx and thyroid: Two case reports on metastasis developing years after nephrectomy. Can Urol Assoc J. 2012; 6(5):E209-12.
PMC: 3478395.
DOI: 10.5489/cuaj.11255.
View
18.
Bianchi M, Sun M, Jeldres C, Shariat S, Trinh Q, Briganti A
. Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol. 2011; 23(4):973-80.
DOI: 10.1093/annonc/mdr362.
View
19.
Barnes L
. Metastases to the head and neck: an overview. Head Neck Pathol. 2010; 3(3):217-24.
PMC: 2811631.
DOI: 10.1007/s12105-009-0123-4.
View
20.
Ljungberg B
. The role of metastasectomy in renal cell carcinoma in the era of targeted therapy. Curr Urol Rep. 2012; 14(1):19-25.
DOI: 10.1007/s11934-012-0293-6.
View